Preferred Label : Bile acid synthesis defect, congenital, 1;
Symbol : CBAS1;
CISMeF acronym : CBAS1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : 3-beta-hydroxy-delta-5-c27-steroid oxidoreductase deficiency;
Description : Congenital defects of bile acid synthesis are autosomal recessive disorders characterized
by neonatal onset of progressive liver disease with cholestatic jaundice and malabsorption
of lipids and lipid-soluble vitamins from the gastrointestinal tract resulting from
a primary failure to synthesize bile acids. Affected infants show failure to thrive
and secondary coagulopathy. In most forms of the disorder, there is a favorable response
to oral bile acid therapy (summary by Cheng et al., 2003). - Genetic Heterogeneity
of Congenital Defects in Bile Acid Synthesis There are several disorders that result
from defects in bile acid synthesis. See CBAS2 (235555), caused by mutation in the
delta(4)-3-oxosteroid 5-beta-reductase gene (AKR1D1; 604741) on chromosome 7q32; CBAS3
(613812), caused by mutation in the 7-alpha hydroxylase gene (CYP7B1; 603711) on chromosome
8q21; and CBAS4 (214950), caused by mutation in the AMACR gene (604489) on chromosome
5. See also progressive familial intrahepatic cholestasis (PFIC1; 211600), which has
a similar phenotype.;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutation in the 3-beta-hydroxy-delta-5-C27-steroid oxidoreductase gene (HSD3B7,
607764.0001);
Laboratory abnormalities : Increased serum bilirubin; Abnormal liver function tests; Decreased serum cholesterol; Normal serum levels of gamma-GGT (231950);
Prefixed ID : #607765;
Origin ID : 607765;
UMLS CUI : C1843116;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT